You have full text access to this OnlineOpen article

Does dabigatran improve stroke-prevention in atrial fibrillation? Reply to a rebuttal

  1. J. W. EIKELBOOM1,
  2. L. WALLENTIN2,
  3. S. YUSUF1,
  4. M. D. EZEKOWITZ3,
  5. P. A. REILLY4,
  6. M. BRUECKMANN5,
  7. A. CLEMENS5,
  8. S. J. CONNOLLY1

Article first published online: 9 FEB 2010

DOI: 10.1111/j.1538-7836.2010.03803.x

Issue

Journal of Thrombosis and Haemostasis

Journal of Thrombosis and Haemostasis

Volume 8, Issue 6, pages 1438–1439, June 2010

Additional Information

How to Cite

EIKELBOOM, J. W., WALLENTIN, L., YUSUF, S., EZEKOWITZ, M. D., REILLY, P. A., BRUECKMANN, M., CLEMENS, A. and CONNOLLY, S. J. (2010), Does dabigatran improve stroke-prevention in atrial fibrillation? Reply to a rebuttal. Journal of Thrombosis and Haemostasis, 8: 1438–1439. doi: 10.1111/j.1538-7836.2010.03803.x

Author Information

  1. 1

    Population Health Research Institute, McMaster University, Hamilton, ON, Canada

  2. 2

    Uppsala Clinical Research Centre, Uppsala University, Uppsala, Sweden

  3. 3

    Lankenau Institute for Medical Research and The Heart Center, Wynnewood, PA

  4. 4

    Boehringer-Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA

  5. 5

    CD Medical Affairs, Boehringer Ingelheim GmbH, Ingelheim, Germany

*John Eikelboom, David Braley Cardiac, Vascular and Stroke Research Institute, 237 Barton Street East, Hamilton, ON L8L 2X2, Canada. Tel.: +1 905 527 4322 (ext) 40323; fax: +1 905 297 3785. E-mail: eikelbj@mcmaster.ca

Publication History

  1. Issue published online: 7 JUN 2010
  2. Article first published online: 9 FEB 2010

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (80K)

No abstract is available for this article.

View Full Article (HTML) Get PDF (80K)